Industry Update: Biotechnology
VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Biotechnology industry including recent transactions, market multiples, company performance and purchase price allocation percentages.
- On January 4, 2023, Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, announced they entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million. OriCiro’s technology strategically complements Moderna’s manufacturing expertise and further accelerates their research and development engine.